1. Informing patients about potential adverse drug reactions after percutaneous coronary intervention reduces the occurrence of self-reported adverse drug reactions. (3rd October 2022) Authors: Pettersen, T; Schjott, J; Allore, H; Bendz, B; Borregaard, B; Fridlund, B; Hadjistavropoulos, H D; Larsen, A I; Nordrehaug, J E; Rasmussen, T B; Rotevatn, S; Valaker, I; Wentzel-Larsen, T; Norekval, T M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗